FDA approves dupilumab for atopic dermatitis in teenagers

posted in: Pediatric News | 0

FDA approves dupilumab for atopic dermatitis in teenagers

Reuters (3/11, Mishra, Mathias) reports the Food and Drug Administration approved Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis in younger patients. The article notes that the drug was previously approved for adults in 2017.